A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
ConditionChronic Liver Disease (CLD)
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age19-64
SponsorAddpharma Inc.
About this trial
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Eligibility criteria
Qualifiers
- Body mass index (BMI) between 18.5 kg/m2 and 29.9 kg/m2 at the time of screening visit
Subjects aged 19 years or older and under 65 years at the screening visit
Disqualifiers
Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration
Other exclusions applied
Trial design
Treatments tested in this trial
- AD-230, AD-2301
Treatment groups
52 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov